- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07626411
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation (ROXI-EVEREST)
A Phase 3, Randomized, Multicenter, Double-blind Study to Assess Stroke and Systemic Embolism Prevention With REGN7508, a Monoclonal Antibody Against Factor XI, Versus Apixaban in Participants With Atrial Fibrillation (ROXI-EVEREST)
This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called apixaban. The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly.
The aim of the study is to see how safe and effective REGN7508 is in preventing stroke and/or systemic embolism in participants with atrial fibrillation and how it compares against participants that will receive apixaban in this study.
The study is looking at several other research questions, including:
- What side effects may happen from taking the study drug
- Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Fas 3
Kontakter och platser
Studiekontakt
- Namn: Clinical Trials Administrator
- Telefonnummer: 844-734-6643
- E-post: clinicaltrials@regeneron.com
Studieorter
-
-
Alabama
-
Alexander City, Alabama, Förenta staterna, 35010
- Rekrytering
- Advanced Cardiovascular
-
Dothan, Alabama, Förenta staterna, 36305
- Rekrytering
- SEC Clinical Research
-
Fairhope, Alabama, Förenta staterna, 36532
- Rekrytering
- Eastern Shore Research Institute
-
-
Arizona
-
Glendale, Arizona, Förenta staterna, 85306
- Rekrytering
- West Valley Clinical Trials
-
Scottsdale, Arizona, Förenta staterna, 85260
- Rekrytering
- Scottsdale Clinical Trials
-
-
Arkansas
-
Little Rock, Arkansas, Förenta staterna, 72205
- Rekrytering
- Arkansas Cardiology P.A.
-
-
California
-
Covina, California, Förenta staterna, 91723
- Rekrytering
- Valley Clinical Trials, Inc
-
Fremont, California, Förenta staterna, 94538
- Rekrytering
- Mission Cardiovascular Research Institute
-
Huntington Beach, California, Förenta staterna, 92648
- Rekrytering
- National Institute of California Heart and Vein Specialists
-
Inglewood, California, Förenta staterna, 90301
- Rekrytering
- Alliance Clinical Los Angeles
-
La Jolla, California, Förenta staterna, 92037
- Rekrytering
- Profound Research LLC at San Diego Cardiovascular Associates
-
Newport Beach, California, Förenta staterna, 92663
- Rekrytering
- Radin Cardiovascular Medical Group
-
Northridge, California, Förenta staterna, 91325
- Rekrytering
- Valley Clinical Trials, LLC dba Flourish Research
-
Pasadena, California, Förenta staterna, 91105
- Rekrytering
- Southern California Heart Specialists
-
Redding, California, Förenta staterna, 96001
- Rekrytering
- The Cardiovascular Center
-
Santa Maria, California, Förenta staterna, 93454
- Rekrytering
- FOMAT - Comprehensive Cardiovascular Care
-
Ventura, California, Förenta staterna, 93003
- Rekrytering
- Cardiology Associates Medical Group
-
West Hills, California, Förenta staterna, 91307
- Rekrytering
- Interventional Cardiology Medical Group
-
-
Florida
-
Boca Raton, Florida, Förenta staterna, 33434
- Rekrytering
- Excel Medical Clinical Trials, dba Flourish Research
-
Cutler Bay, Florida, Förenta staterna, 33189
- Rekrytering
- Nouvelle Clinical Research LLC
-
Inverness, Florida, Förenta staterna, 34452
- Rekrytering
- Nature Coast Clinical Research - Inverness
-
Jacksonville, Florida, Förenta staterna, 32216
- Rekrytering
- East Coast Institute for Research, Jacksonville
-
Medley, Florida, Förenta staterna, 33166
- Rekrytering
- South Florida Research Organization LLC
-
Miami, Florida, Förenta staterna, 33135
- Rekrytering
- Novera Clinical Research
-
New Smyrna Beach, Florida, Förenta staterna, 32168
- Rekrytering
- Healix Clinical Research
-
Pensacola, Florida, Förenta staterna, 32503
- Rekrytering
- Sec Clinical Research
-
Saint Augustine, Florida, Förenta staterna, 32086
- Rekrytering
- Flourish Research, St. Johns Center for Clinical Research
-
Saint Augustine, Florida, Förenta staterna, 32086
- Rekrytering
- East Coast Institute for Research, St. Augustine
-
Sarasota, Florida, Förenta staterna, 34239
- Rekrytering
- Cardiovascular Center of Sarasota Foundation for Research and Education
-
Winter Park, Florida, Förenta staterna, 32789
- Rekrytering
- Clinical Site Partners, LLC DBA Flourish Research
-
-
Georgia
-
Atlanta, Georgia, Förenta staterna, 30342
- Rekrytering
- Atlanta Clinical Research Centers
-
Atlanta, Georgia, Förenta staterna, 30310
- Rekrytering
- Morehouse School Of Medicine
-
Johns Creek, Georgia, Förenta staterna, 30024
- Rekrytering
- NSC Research, Inc
-
-
Indiana
-
Hobart, Indiana, Förenta staterna, 46342
- Rekrytering
- Profound Research, Advanced Cardiovascular Care + Electrophysiology Clinic
-
Indianapolis, Indiana, Förenta staterna, 46237
- Rekrytering
- Franciscan Physician Network, Indiana Heart Physicians
-
Munster, Indiana, Förenta staterna, 46321
- Rekrytering
- Profound Research, Powers Health Medical Group - Electrophysiology
-
Munster, Indiana, Förenta staterna, 46321-4054
- Rekrytering
- Cardiovascular Research of Northwest Indiana, LLC
-
-
Louisiana
-
West Monroe, Louisiana, Förenta staterna, 71291
- Rekrytering
- Monroe Research, LLC
-
-
Maryland
-
Ft. Washington, Maryland, Förenta staterna, 20744
- Rekrytering
- Anderson Medical Research
-
-
Massachusetts
-
Foxborough, Massachusetts, Förenta staterna, 02035
- Rekrytering
- K2 Medical Research, Foxboro
-
-
Michigan
-
Bloomfield Hills, Michigan, Förenta staterna, 48304
- Rekrytering
- Profound Research, Cardiology and Vascular Associates (CAVA) - Bloomfield Hills
-
Farmington Hills, Michigan, Förenta staterna, 48334
- Rekrytering
- Profound Research, Millennium Cardiology
-
Flint, Michigan, Förenta staterna, 48503
- Rekrytering
- Flint Clinical Research
-
Flint, Michigan, Förenta staterna, 48504
- Rekrytering
- AA Medical Research Center (MRC)
-
-
New York
-
Staten Island, New York, Förenta staterna, 10309
- Rekrytering
- Super Health Pharmacy
-
-
North Carolina
-
Concord, North Carolina, Förenta staterna, 28025
- Rekrytering
- Hawthorne Health, Moose Pharmacy of Concord
-
High Point, North Carolina, Förenta staterna, 27260
- Rekrytering
- Peters Medical Research
-
-
North Dakota
-
Fargo, North Dakota, Förenta staterna, 58104
- Rekrytering
- Lillestol Research LLC
-
-
Ohio
-
Marion, Ohio, Förenta staterna, 43302
- Rekrytering
- K&R Research LLC
-
Maumee, Ohio, Förenta staterna, 43537
- Rekrytering
- Advanced Medical Research
-
-
South Dakota
-
Rapid City, South Dakota, Förenta staterna, 57701
- Rekrytering
- Monument Health Clinical Research
-
-
Tennessee
-
Knoxville, Tennessee, Förenta staterna, 37912
- Rekrytering
- Norwood Family Medicine
-
Tullahoma, Tennessee, Förenta staterna, 37388
- Rekrytering
- Tennessee Center for Clinical Trials
-
-
Texas
-
Amarillo, Texas, Förenta staterna, 79106
- Rekrytering
- PharmaTex Research
-
Brownsville, Texas, Förenta staterna, 78520
- Rekrytering
- PanAmerican Clinical Research
-
Houston, Texas, Förenta staterna, 77061
- Rekrytering
- Synergy Groups Medical
-
Houston, Texas, Förenta staterna, 77094
- Rekrytering
- West Houston Area Clinical Trial Consultants, LLC
-
Houston, Texas, Förenta staterna, 77036
- Rekrytering
- Synergy Group Medical
-
McKinney, Texas, Förenta staterna, 75071
- Rekrytering
- Texas Institute of Cardiology PA
-
Missouri City, Texas, Förenta staterna, 77459
- Rekrytering
- Synergy Group Medical, LLC
-
Odessa, Texas, Förenta staterna, 79761
- Rekrytering
- Permian Research Foundation
-
Tyler, Texas, Förenta staterna, 75701
- Rekrytering
- Tyler Cardiovascular Consultants
-
-
Utah
-
Clinton, Utah, Förenta staterna, 84015
- Rekrytering
- Alpine Research TC
-
Provo, Utah, Förenta staterna, 84604
- Rekrytering
- Boeson Research PVU
-
-
Virginia
-
Manassas, Virginia, Förenta staterna, 20109
- Rekrytering
- Carient Heart & Vascular
-
Vienna, Virginia, Förenta staterna, 22182
- Rekrytering
- Conquest Research
-
-
-
-
Aichi-ken
-
Nagoya, Aichi-ken, Japan, 466-8650
- Rekrytering
- Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital
-
-
Ehime
-
Uwajima, Ehime, Japan, 798-8510
- Rekrytering
- Uwajima City Hospital
-
-
Fukuoka
-
Onga District, Fukuoka, Japan, 811-4342
- Rekrytering
- Onga Nakama Medical Association Onga Hospital
-
-
Gifu
-
Gifu, Gifu, Japan, 500-8717
- Rekrytering
- Gifu Prefectural General Medical Center - Main Hospital Building
-
-
Hokkaido
-
Sapporo, Hokkaido, Japan, 062-0003
- Rekrytering
- Hanaoka Seishu Memorial Hospital
-
-
Hyōgo
-
Kawanishi, Hyōgo, Japan, 666-0125
- Rekrytering
- The Veritas Hospital
-
-
Ibaraki
-
Higashiibaraki District, Ibaraki, Japan, 311-3193
- Rekrytering
- National Hospital Organization Mito Medical Center
-
Tsuchiura, Ibaraki, Japan, 300-8585
- Rekrytering
- National Hospital Organization Kasumigaura Medical Center
-
-
Kanagawa
-
Yokohama, Kanagawa, Japan, 234-0054
- Rekrytering
- Saiseikai Yokohama-shi Nanbu Hospital
-
-
Kyoto
-
Kyoto, Kyoto, Japan, 607-8062
- Rekrytering
- Rakuwakai Otowa Hospital
-
-
Shizuoka
-
Shizuoka, Shizuoka, Japan, 420-8630
- Rekrytering
- Shizuoka City Shizuoka Hospital, East Building
-
-
Tokyo
-
Hachiōji, Tokyo, Japan, 192-0918
- Rekrytering
- Minamino Cardiovascular Hospital
-
Suginami Ward, Tokyo, Japan, 168-0065
- Rekrytering
- NewHeart Watanabe International Hospital
-
-
Yokohama-shi
-
Kanagawa, Yokohama-shi, Japan, 247-0005
- Rekrytering
- JA Tsuchiura Kyodo General Hospital
-
-
-
-
-
Longueuil, Kanada, J4H4B9
- Rekrytering
- Viacar Recherches Cliniques inc.
-
-
Ontario
-
Hamilton, Ontario, Kanada, L8L 5G4
- Rekrytering
- Premiere Clinical Trial Network
-
Scarborough Village, Ontario, Kanada, M1B 4Z8
- Rekrytering
- Heart Health Institute Research Inc.
-
-
Quebec
-
Sherbrooke, Quebec, Kanada, J1LOK3
- Rekrytering
- Diex Recherche Inc.
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Key Inclusion Criteria:
-
Has AF or flutter (paroxysmal or persistent), not considered to be secondary to a reversible cause, and an indication for indefinite anticoagulation treatment as described in the protocol
-
Meets one of the following:
- CHA2DS2-VA [C: Congestive heart failure; H: Hypertension; A2: Age ≥75 years (double points); D: Diabetes mellitus; S2: Stroke or TIA or Systemic embolism (double points); V: Vascular disease; A: Age 65-74 years] score ≥2 and Oral Anticoagulant (OAC) naïve OR
- CHA2DS2-VA score ≥3 OR
- CHA2DS2-VA score of 2 AND at least 1 enrichment criteria as described in the protocol
-
Must have an International Normalized Ratio (INR) <2.5 at the time of randomization if taking warfarin or another Vitamin K Antagonist (VKA)
Key Exclusion Criteria:
- Has a mechanical heart valve prosthesis (Note: transcatheter aortic valve replacement is not an exclusion)
- Has known moderate-to-severe mitral stenosis
- Has had a successful ablation therapy without documented recurrent AF or a participant after Left Atrial Appendage (LAA) occlusion/exclusion or plan for ablation or LAA occlusion/exclusion within the next 6 months starting from randomization
- Had an ischemic stroke within 2 days prior to randomization
- Has persistent, uncontrolled hypertension (per investigator's discretion)
- Has estimated Glomerular Filtration Rate (eGFR) <15 mL/min/1.73m2 within 30 days prior to randomization or is on dialysis or expected to be started on dialysis within the next 6 months starting from randomization
Note: Other protocol-defined Inclusion/ Exclusion criteria apply
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Fyrdubbla
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: REGN7508 + Placebo
|
Administered per the protocol Administered per the protocol
Andra namn:
|
|
Aktiv komparator: Apixaban + Placebo
|
Administered per the protocol Administered per the protocol |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Time to first occurrence of stroke (ischemic, hemorrhagic, or of unspecified type) or systemic embolism
Tidsram: Approximately 36 months
|
Approximately 36 months
|
|
Time to first occurrence of International Society on Thrombosis and Haemostasis (ISTH) major bleeding or ISTH Clinically Relevant Non-Major (CRNM) bleeding
Tidsram: Approximately 36 months
|
Approximately 36 months
|
Sekundära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Time to first occurrence of stroke (ischemic, hemorrhagic, or of unspecified type), systemic embolism, ISTH major bleeding, or ISTH CRNM bleeding
Tidsram: Approximately 36 months
|
Approximately 36 months
|
|
Time to first occurrence of stroke (ischemic, hemorrhagic, or of unspecified type), systemic embolism, or ISTH major bleeding
Tidsram: Approximately 36 months
|
Approximately 36 months
|
|
Time to first occurrence of stroke (ischemic, hemorrhagic, or of unspecified type), systemic embolism, ISTH major bleeding, or all-cause death
Tidsram: Approximately 36 months
|
Approximately 36 months
|
|
Time to first occurrence of ISTH major bleeding
Tidsram: Approximately 36 months
|
Approximately 36 months
|
|
Time to first occurrence of hemorrhagic stroke, intracerebral hemorrhage, or hemorrhagic transformation of an ischemic stroke
Tidsram: Approximately 36 months
|
Approximately 36 months
|
|
Time to occurrence of fatal bleeding
Tidsram: Approximately 36 months
|
Approximately 36 months
|
|
Number of ISTH major bleeding events
Tidsram: Approximately 36 months
|
Approximately 36 months
|
|
Number of ISTH CRNM bleeding events
Tidsram: Approximately 36 months
|
Approximately 36 months
|
|
Number of minor bleeding events
Tidsram: Approximately 36 months
|
Approximately 36 months
|
|
Time to all-cause death
Tidsram: Approximately 36 months
|
Approximately 36 months
|
|
Occurrence of Treatment-Emergent Adverse Events (TEAEs)
Tidsram: Approximately 39 months
|
Approximately 39 months
|
|
Severity of TEAEs
Tidsram: Approximately 39 months
|
Approximately 39 months
|
|
Occurrence of Anti-Drug Antibodies (ADA) to REGN7508
Tidsram: Approximately 36 months
|
Approximately 36 months
|
|
Magnitude of ADA to REGN7508
Tidsram: Approximately 36 months
|
Approximately 36 months
|
Samarbetspartners och utredare
Sponsor
Utredare
- Studierektor: Clinical Trial Management, Regeneron Pharmaceuticals
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- R7508-CVA-24114
- 2025-521617-97-00 (Ctis)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
All Individual Patient Data (IPD) that underlie publicly available results will be considered for sharing
Tidsram för IPD-delning
When Regeneron has:
- received marketing authorization from major health authorities (e.g., FDA, European Medicines Agency (EMA), Pharmaceuticals and Medical Devices Agency (PMDA), etc.) for the product and indication or has globally discontinued development of the product for all indications on or after April 2020 and has no plans for future development
- made the study results publicly available (e.g., scientific publication, scientific conference, clinical trial registry)
- the legal authority to share the data, and
- ensured the ability to protect participant privacy
Kriterier för IPD Sharing Access
Qualified researchers can submit a proposal for access to individual patient or aggregate level data from a Regeneron-sponsored clinical trial through Vivli. Regeneron's Independent Research Request Evaluation Criteria can be found at: https://www.regeneron.com/sites/default/files/Regeneron-External-Data-Sharing-Policy-and-Independent-Research-Request-Evaluation-Criteria.pdf
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- SAV
- ICF
- ANALYTIC_CODE
- CSR
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .